The non-invasive liquid biopsy technique uses samples such as stool, urine, saliva, and other samples, which are extracted without inserting any medical device into the patient’s body. These samples help healthcare professionals to identify biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), circulating messenger RNA (mRNA), circulating microRNA (miRNA), DNA methylation-based biomarkers, exosomes, and extracellular vesicles (EVs). Extensive research is being conducted worldwide for the discovery and presence of novel biomarkers in these samples, which is expected to support the healthcare continuum to conduct liquid biopsy without penetrating any minimally invasive device into the patient’s body.

1. Product Definition 

2. Market Scope 

3. Research Methodology 

4. Market Overview 

5. Industry Analysis 

6. Market Dynamics 

7. Competitive Landscape

8. Global Non-Invasive Liquid Biopsy Market (by Offering), $Million, 2020-2031 . 81

9. Global Non-Invasive Liquid Biopsy Market (by Sample), $Million, 2021-2031 .. 89

10. Global Non-Invasive Liquid Biopsy Market (by Application), $Million, 2020-2031

11. Global Non-Invasive Liquid Biopsy Market (by Technology), $Million, 2020-2031